statistiche ricercatore

Continente	#
NA - Nord America	966
AS - Asia	314
EU - Europa	172
SA - Sud America	47
Continente sconosciuto - Info sul continente non disponibili	38
AF - Africa	11
Totale	1.548

Nazione	#
US - Stati Uniti d'America	947
SG - Singapore	154
CN - Cina	56
IT - Italia	31
UA - Ucraina	30
BR - Brasile	29
DE - Germania	28
VN - Vietnam	26
HK - Hong Kong	22
IN - India	21
RU - Federazione Russa	20
BD - Bangladesh	14
FR - Francia	14
SE - Svezia	11
CA - Canada	10
AR - Argentina	6
GB - Regno Unito	6
IQ - Iraq	6
IE - Irlanda	5
MX - Messico	5
BE - Belgio	4
NL - Olanda	4
TR - Turchia	4
VE - Venezuela	4
CZ - Repubblica Ceca	3
FI - Finlandia	3
LT - Lituania	3
EC - Ecuador	2
EG - Egitto	2
ES - Italia	2
ID - Indonesia	2
JM - Giamaica	2
JP - Giappone	2
PL - Polonia	2
PY - Paraguay	2
SN - Senegal	2
TN - Tunisia	2
UY - Uruguay	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AT - Austria	1
BG - Bulgaria	1
BO - Bolivia	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
CO - Colombia	1
DZ - Algeria	1
EU - Europa	1
JO - Giordania	1
KE - Kenya	1
LV - Lettonia	1
NI - Nicaragua	1
NP - Nepal	1
SA - Arabia Saudita	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
Totale	1.511

Nome	#
First steps in the definition of a prognostic score based on MGMT methylation status in patients with glioblastoma	197
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme	191
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme	175
Molecular and clinical prognostic factors in metastatic colorectal cancer (CRC) patients (pts): A retrospective study	169
Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approach	168
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer	146
Heart transplantation in Kearns-Sayre syndrome	145
Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlations.	140
Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach	111
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic non-squamous NSCLC	106
Totale	1.548

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	108	0	9	4	3	3	8	8	2	2	17	39	13
2022/2023	107	10	5	8	6	16	19	0	16	18	0	7	2
2023/2024	45	3	3	3	6	9	13	0	2	4	1	0	1
2024/2025	219	5	11	17	19	23	10	11	14	38	11	26	34
2025/2026	436	67	42	19	68	71	27	37	8	31	31	33	2
2026/2027	7	7	0	0	0	0	0	0	0	0	0	0	0
Totale													1.548